Cancer immunotherapy based on the killing of Salmonella typhimurium-infected tumour cells.
about
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model.Tumor-targeting bacterial therapy: A potential treatment for oral cancer (Review)Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.EGFR-targeted Chimeras of Pseudomonas ToxA released into the extracellular milieu by attenuated Salmonella selectively kill tumor cells.Salmonella-host cell interactions, changes in host cell architecture, and destruction of prostate tumor cells with genetically altered Salmonella.
P2860
Cancer immunotherapy based on the killing of Salmonella typhimurium-infected tumour cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cancer immunotherapy based on ...... imurium-infected tumour cells.
@ast
Cancer immunotherapy based on ...... imurium-infected tumour cells.
@en
type
label
Cancer immunotherapy based on ...... imurium-infected tumour cells.
@ast
Cancer immunotherapy based on ...... imurium-infected tumour cells.
@en
prefLabel
Cancer immunotherapy based on ...... imurium-infected tumour cells.
@ast
Cancer immunotherapy based on ...... imurium-infected tumour cells.
@en
P2860
P356
P1476
Cancer immunotherapy based on ...... imurium-infected tumour cells.
@en
P2093
Daniel A Saltzman
P2860
P304
P356
10.1517/14712598.5.4.443
P407
P577
2005-04-01T00:00:00Z